Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.verified

AMLX

Price:

$1.825

Market Cap:

$124.11M

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.[Read more]

Industry

Biotechnology

IPO Date

2022-01-07

Stock Exchange

NASDAQ

Ticker

AMLX

The ROE as of June 2024 (TTM) for Amylyx Pharmaceuticals, Inc. (AMLX) is -18.20%

According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -18.20%. This represents a change of 193.33% compared to the average of -6.20% of the last 4 quarters.

Amylyx Pharmaceuticals, Inc. (AMLX) Historical ROE (quarterly & annually)

How has AMLX ROE performed in the past?

The mean historical ROE of Amylyx Pharmaceuticals, Inc. over the last ten years is 27.38%. The current -18.20% ROE has changed -166.47% with respect to the historical average. Over the past ten years (40 quarters), AMLX's ROE was at its highest in in the December 2021 quarter at 18.75%. The ROE was at its lowest in in the September 2022 quarter at -37.32%.

Quarterly (TTM)
Annual

Average

27.38%

Median

58.13%

Minimum

-58.24%

Maximum

67.20%

Amylyx Pharmaceuticals, Inc. (AMLX) ROE by Quarter and Year

Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 15.00%

Maximum Annual ROE = 67.20%

Minimum Annual Increase = -200.19%

Minimum Annual ROE = -58.24%

Quarterly (TTM)
Annual
YearROEChange
202311.37%-119.52%
2022-58.24%-200.19%
202158.13%-13.49%
202067.20%15.00%

Amylyx Pharmaceuticals, Inc. (AMLX) Average ROE

How has AMLX ROE performed in the past?

The current ROE of Amylyx Pharmaceuticals, Inc. (AMLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.75%

5-year avg

27.38%

10-year avg

27.38%

Amylyx Pharmaceuticals, Inc. (AMLX) ROE vs. Peers

How is AMLX’s ROE compared to its peers?

Amylyx Pharmaceuticals, Inc.’s ROE is greater than Terns Pharmaceuticals, Inc. (-35.55%), greater than Acumen Pharmaceuticals, Inc. (-22.87%), greater than Inozyme Pharma, Inc. (-58.74%), greater than X4 Pharmaceuticals, Inc. (-275.36%), greater than Day One Biopharmaceuticals, Inc. (-125.61%), greater than Mereo BioPharma Group plc (-67.33%), greater than PDS Biotechnology Corporation (-145.99%), greater than HOOKIPA Pharma Inc. (-47.31%),

Build a custom stock screener for Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Amylyx Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the highest ROE for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the 3-year average ROE for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the 5-year average ROE for Amylyx Pharmaceuticals, Inc. (AMLX)?

How does the current ROE for Amylyx Pharmaceuticals, Inc. (AMLX) compare to its historical average?